CD8+ T cell activation in cancer comprises an initial activation phase in lymph nodes followed by effector differentiation within the tumor
Nataliya Prokhnevska, Maria A. Cardenas, Rajesh M. Valanparambil, Ewelina Sobierajska, Benjamin G. Barwick, Caroline S. Jansen, Adriana Reyes Moon, Petra Gregorova, Luke del Balzo, Rachel Greenwald, Mehmet Asım Bilen, Mehrdad Alemozaffar, Shreyas Joshi, Cara Cimmino, Christian P. Larsen, Viraj A. Master, Martin G. Sanda, Haydn Kissick
Topics & Concepts
Cytotoxic T cellBiologyCD8Cancer researchEffectorT cellCell biologyImmunologyAntigenImmune systemIn vitroGeneticsImmunotherapy and Immune ResponsesCancer Immunotherapy and BiomarkersImmune Cell Function and Interaction